Nutraceuticals - An Emerging Era in the Treatment and Prevention of Cardiovascular Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
7
Page:
15-23
Author(s):
C. S. Ramaa, A. R. Shirode, A. S. Mundada and V. J. Kadam
Novel Agents Aiming at Specific Molecular Targets Increase Chemosensitivity and Overcome Chemoresistance in Hematopoietic Malignancies
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
111-128
Author(s):
Simone Boehrer, Daniel Nowak, Dieter Hoelzer, Paris S. Mitrou and Kai U. Chow
Thrombolytic Therapy in Acute Ischemic Stroke - Basic Concepts
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
31-44
Author(s):
Atte Meretoja and Turgut Tatlisumak
Telmisartan, its Potential Therapeutic Implications in Cardiometabolic Disorders
Journal:
Recent Patents on Cardiovascular Drug Discovery
Volume:
1
Page:
79-83
Author(s):
Sho-ichi Yamagishi and Kazuo Nakamura
Hypertensive Pharmacogenomics in African Americans
Journal:
Current Pharmacogenomics
Volume:
3
Page:
271-279
Author(s):
Arlene Chapman, Frieda Millhouse-Jones, Janice Lea, Frederic Rahbari and Evelyn Baranco-Pryor
Analgesia in PACU: Nonsteroidal Anti-Inflammatory Drugs
Journal:
Current Drug Targets
Volume:
6
Page:
781-787
Author(s):
G. D. Rocca, P. Chiarandini and P. Pietropaoli
What Does a Pediatrician Need to Know About Chronic Diarrhea?
Journal:
Current Pediatric Reviews
Volume:
1
Page:
253-260
Author(s):
Mukadder A. Selimoglu and Vildan Ertekin
New Challenges for ACE-Inhibitors in Vascular Diseases
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
2
Page:
485-493
Author(s):
Claudio Napoli and Joseph Loscalzo
Complement Activation-Related Pseudoallergy Caused by Amphiphilic Drug Carriers: The Role of Lipoproteins
Journal:
Current Drug Delivery
Volume:
2
Page:
443-449
Author(s):
Janos Szebeni
Vasopeptidase Inhibition for Blood Pressure Control: Emerging Experience
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
3293-3299
Author(s):
T. Quaschning